Drug related deaths in England and Wales

Middleton, John; McGrail, Sara; Stringer, K. R.

doi:10.1136/bmj.i5259

Cited by 26 publications

(19 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…32 This mortality problem in this age group in the USA is at least partly driven by a combination of socioeconomic deprivation and a major problem of misuse of medicinal opioids. 33 However, although drug-related deaths in England and Wales have increased, 34 to date the increase has been on a smaller scale. 33 Further research to understand why adult mortality rates in England and Wales at working age and older ages are faltering relative to many other countries must be prioritised.…”

Section: Discussionmentioning

confidence: 99%

Trends in life expectancy and age-specific mortality in England and Wales, 1970–2016, in comparison with a set of 22 high-income countries: an analysis of vital statistics data

Leon

Jdanov

Shkolnikov

2019

The Lancet Public Health

View full text Add to dashboard Cite

Background Since 2010, the rate of improvement in life expectancy in the UK has slowed. We aimed to put this trend in the context of changes over the long term and in relation to a group of other high-income countries. Methods We compared sex-specific trends in life expectancy since 1970 and age-specific mortality in England and Wales with median values for 22 high-income countries (in western Europe, Australia, Canada, New Zealand, Japan, and the USA). We used annual mortality data (1970-2016) from the Human Mortality Database. Findings Until 2011-16, male life expectancy in England and Wales followed the median life expectancy of the comparator group. By contrast, female life expectancy was below the median and is among the lowest of the countries considered. In 2011-16, the rate of improvement in life expectancy slowed sharply for both sexes in England and Wales, and slowed more moderately in the comparator group because of negative trends in all adult age groups. This deceleration resulted in a widening gap between England and Wales and the comparators from 2011 onwards. Since the mid-2000s, for the first time, mortality rates in England and Wales among people aged 25-50 years were appreciably higher than in the comparator group. Interpretation Although many countries have seen slower increases in life expectancy since 2011, trends in England and Wales are among the worst. The poor performance of female life expectancy over the long-term is in part driven by the relative timing of the smoking epidemic across countries. The previously overlooked higher mortality among young working-age adults in England and Wales relative to other countries deserves urgent attention.

show abstract

Section: Discussionmentioning

confidence: 99%

Trends in life expectancy and age-specific mortality in England and Wales, 1970–2016, in comparison with a set of 22 high-income countries: an analysis of vital statistics data

Leon

Jdanov

Shkolnikov

2019

The Lancet Public Health

View full text Add to dashboard Cite

show abstract

“…1,2 Recently, drug-related problems and mortality have become extremely dangerous to the public. [3][4][5][6][7][8] It is affecting patient safety and causes more economic burden on the healthcare system. [9][10][11][12] In order to prevent drug-related problems, the healthcare team, including the pharmacist, should choose the best medications for patient which might show greater efficacy and safety.…”

Section: Introductionmentioning

confidence: 99%

Drug Evaluation Steps of Ministry of Health Drug Formulary in Saudi Arabia

Alomi¹,

Alghamdi²,

Alattyh³

2019

PTB Reports

View full text Add to dashboard Cite

Objective: To illustrate the Drug Evaluation Steps of Ministry of Health Drug Formulary at Health care institutions in the Kingdom of Saudi Arabia. Method: It is description analysis of Drug Evaluation Steps of drug information service at the Ministry of Health of Health institutions. The modified pharmacy business model system and Project Management Procedure used in the report. Results: The Drug Evaluation Steps established with a defined vision, mission and goals. The system human or economic and other resources described in the review. The risk management was discussed to assure the continuation of the system. Besides, the monitoring and controlling of the system as illustrated. The closing stage with convention to operation project demonstrated in the analysis. Conclusion: The drug evaluation steps system implemented and it is considered as part of the health care system and drug information centers regulations. The drug evaluation Steps needs the continuous updating accordingly at all Ministry of Health strategic planning in the Kingdom of Saudi Arabia.

show abstract

“…That has included a visit the doctor at ambulatory care clinic or emergency visit, hospital admission, or critical care admission or death. [3][4][5][6][7][8][9][10][11] Most of the studies done retrospective or perspective with follow up. There's not involved the patient respective and view.…”

Section: Introductionmentioning

confidence: 99%